602 related articles for article (PubMed ID: 18539959)
1. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy.
Kakarala M; Wicha MS
J Clin Oncol; 2008 Jun; 26(17):2813-20. PubMed ID: 18539959
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Potential, Challenges and Future Perspective of Cancer Stem Cells in Translational Oncology: A Critical Review.
Shukla G; Khera HK; Srivastava AK; Khare P; Patidar R; Saxena R
Curr Stem Cell Res Ther; 2017; 12(3):207-224. PubMed ID: 27804866
[TBL] [Abstract][Full Text] [Related]
3. Cancer stem cells in breast: current opinion and future challenges.
Charafe-Jauffret E; Monville F; Ginestier C; Dontu G; Birnbaum D; Wicha MS
Pathobiology; 2008; 75(2):75-84. PubMed ID: 18544962
[TBL] [Abstract][Full Text] [Related]
4. Notch Signaling in Breast Cancer: A Role in Drug Resistance.
BeLow M; Osipo C
Cells; 2020 Sep; 9(10):. PubMed ID: 33003540
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic cancer stem cells.
Lee CJ; Dosch J; Simeone DM
J Clin Oncol; 2008 Jun; 26(17):2806-12. PubMed ID: 18539958
[TBL] [Abstract][Full Text] [Related]
6. Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells.
Pavlopoulou A; Oktay Y; Vougas K; Louka M; Vorgias CE; Georgakilas AG
Cancer Lett; 2016 Oct; 380(2):485-493. PubMed ID: 27450721
[TBL] [Abstract][Full Text] [Related]
7. Medulloblastoma stem cells.
Fan X; Eberhart CG
J Clin Oncol; 2008 Jun; 26(17):2821-7. PubMed ID: 18539960
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer stem cells: a new challenge for breast cancer treatment.
Jain P; Alahari SK
Front Biosci (Landmark Ed); 2011 Jan; 16(5):1824-32. PubMed ID: 21196267
[TBL] [Abstract][Full Text] [Related]
9. Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival.
Baker A; Wyatt D; Bocchetta M; Li J; Filipovic A; Green A; Peiffer DS; Fuqua S; Miele L; Albain KS; Osipo C
Oncogene; 2018 Aug; 37(33):4489-4504. PubMed ID: 29743588
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.
Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N
Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295
[TBL] [Abstract][Full Text] [Related]
11. Stem cells of the breast and cancer therapy.
Groner B; Vafaizadeh V; Brill B; Klemmt P
Womens Health (Lond); 2010 Mar; 6(2):205-19. PubMed ID: 20187727
[TBL] [Abstract][Full Text] [Related]
12. [Signal pathways in breast cancer stem cells and the targeted stem cell therapy].
Ma Y; Wang HX
Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):881-5. PubMed ID: 21223793
[No Abstract] [Full Text] [Related]
13. Targeting breast cancer stem cells.
Liu S; Wicha MS
J Clin Oncol; 2010 Sep; 28(25):4006-12. PubMed ID: 20498387
[TBL] [Abstract][Full Text] [Related]
14. Stem cell therapy for hereditary breast cancer.
Rassi H
Tsitol Genet; 2009; 43(3):80-8. PubMed ID: 19938640
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells: an old idea--a paradigm shift.
Wicha MS; Liu S; Dontu G
Cancer Res; 2006 Feb; 66(4):1883-90; discussion 1895-6. PubMed ID: 16488983
[TBL] [Abstract][Full Text] [Related]
16. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.
Takebe N; Harris PJ; Warren RQ; Ivy SP
Nat Rev Clin Oncol; 2011 Feb; 8(2):97-106. PubMed ID: 21151206
[TBL] [Abstract][Full Text] [Related]
17. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
18. Mammary development and breast cancer: the role of stem cells.
Ercan C; van Diest PJ; Vooijs M
Curr Mol Med; 2011 Jun; 11(4):270-85. PubMed ID: 21506923
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation.
Grudzien P; Lo S; Albain KS; Robinson P; Rajan P; Strack PR; Golde TE; Miele L; Foreman KE
Anticancer Res; 2010 Oct; 30(10):3853-67. PubMed ID: 21036696
[TBL] [Abstract][Full Text] [Related]
20. Targeting breast stem cells with the cancer preventive compounds curcumin and piperine.
Kakarala M; Brenner DE; Korkaya H; Cheng C; Tazi K; Ginestier C; Liu S; Dontu G; Wicha MS
Breast Cancer Res Treat; 2010 Aug; 122(3):777-85. PubMed ID: 19898931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
